Mancini Anthony Insider Trading -- Recent SEC Form 4 Transactions
Mancini Anthony (CIK 2124509) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-28). Recent activity: Sell RVMD (587 shares), Buy RVMD (3,121 shares), Sell RVMD (3,121 shares), Sell RVMD (1,764 shares), Sell RVMD (27 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 587 | $117,400 |
| 2026-09-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Buy | 3,121 | $104,928 |
| 2026-09-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 3,121 | $625,885 |
| 2026-09-22 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,764 | $347,402 |
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 27 | $5,266 |
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,747 | $348,183 |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Buy | 9,363 | $314,784 |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 6,019 | $1.2M |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 5,530 | $1.1M |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 2,420 | $496,224 |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,179 | $242,991 |
| 2026-09-14 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 300 | $62,152 |
| 2026-06-18 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 4,615 | $720,494 |
| 2026-05-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Buy | 3,121 | $104,928 |
| 2026-05-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 700 | $107,310 |
| 2026-05-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 2,000 | $308,120 |
| 2026-05-28 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 421 | $65,179 |
| 2026-04-29 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Buy | 3,120 | $104,894 |
| 2026-04-29 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,671 | $220,004 |
| 2026-04-29 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,049 | $139,391 |
| 2026-04-29 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 400 | $53,736 |
| 2026-03-26 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Buy | 37,450 | $1.3M |
| 2026-03-26 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 1,800 | $167,796 |
| 2026-03-26 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 3,128 | $294,532 |
| 2026-03-26 | Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Sell | 21,086 | $2.0M |
Source: SEC Form 4 filings · as of 2026-09-28